In the tumor microenvironment (TME), CD8+ T cells play a major role in killing tumor cells [40], while M2-type macrophages contribute to a suppressive immune microenvironment, with both types of cells influencing the response to immunotherapy [41–43]. Here, CD8A is linked to neoplasm.